ProQR Therapeutics N.V. (FRA:0PQ)

ProQR Therapeutics Revenue

ProQR Therapeutics had revenue of 2.88M EUR in the quarter ending September 30, 2025, a decrease of -25.01%. This brings the company's revenue in the last twelve months to 15.53M, down -13.18% year-over-year. In the year 2024, ProQR Therapeutics had annual revenue of 18.91M with 190.22% growth.

• Revenue (ttm): 15.53M
• Revenue Growth: -13.18%
• P/S Ratio: 8.94
• Revenue / Employee: 96.83K
• Employees: 166
• Market Cap: 143.64M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	18.91M	12.39M	190.22%
Dec 31, 2023	6.51M	2.92M	81.25%
Dec 31, 2022	3.59M	2.26M	169.21%
Dec 31, 2021	1.34M	-8.12M	-85.88%
Dec 31, 2020	9.45M	7.52M	388.98%
Dec 31, 2019	1.93M	-3.83M	-66.45%
Dec 31, 2018	5.76M	4.27M	285.35%
Dec 31, 2017	1.50M	-333.00K	-18.22%
Dec 31, 2016	1.83M	-1.41M	-43.49%
Dec 31, 2015	3.24M	2.92M	933.55%
Dec 31, 2014	313.00K	197.00K	169.83%
Dec 31, 2013	116.00K	93.00K	404.35%
Dec 31, 2012	23.00K	-	-